GSK SYLVER 221971
This app is for registered study participants of GSK SYLVER 221971 only
About GSK SYLVER 221971
This app has been created exclusively for participants in the medical study for GSK SYLVER 221971. It contains Televisit functionality and allows participants to complete questionnaires.
A Phase 1/2 Master Protocol to Assess the Safety and Efficacy of DNA-Damage Repair Inhibitors, as Monotherapies or in Combination with Other Anti-Cancer Agents in Adult Participants with Solid Tumors (SYLVER).
Similar Apps
Medable
Medable is on a mission to enable effective therapies to people faster....
J1I-MC-GZQD
This app has been exclusively created for participants in the medical study...
Avanti
For invited Avanti study participants. You will use this app to consent...
GSK 219685
This app has been created exclusively for participants in the medical study...
GSK 219855 France
You are invited to participate in the GSK BLISSc-ILD OLE study. This...
GSK 221458
This app is specifically intended for participants in the GSK 221458 study...
